Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cbd Life Sciences Inc
(OP:
CBDL
)
0.0006
+0.0001 (+20.00%)
Streaming Delayed Price
Updated: 3:59 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cbd Life Sciences Inc
< Previous
1
2
3
Next >
CBD Life Sciences, Inc. (CBDL) Launches New Line of Kava & Kratom Shots
July 10, 2024
Via
ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Announces Launch of Delta 8 CBD Vape Cartridges
July 08, 2024
Via
ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Looking to Expand Its Brand into Retail Stores Nationwide
June 27, 2024
Via
ACCESSWIRE
CBD Life Sciences Inc. Provides Shareholder Letter Update
June 24, 2024
Via
ACCESSWIRE
CBD Life Sciences Provides Update on Exciting Future Following Completion of Reverse Split; Company Poised to Launch Rebranded CBD Products and Online Presence
April 23, 2024
Via
ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Debuts New Exclusive Delta-8 Product
December 14, 2022
Via
ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Announces Expansion of Product Line
November 09, 2022
Via
ACCESSWIRE
CBD Life Sciences Is Developing A Mobile CBD Store On Wheels
October 20, 2022
LBC Bioscience Inc. a wholly owned subsidiary of CBD Life Sciences (OTCPK:CBDL) is developing a Mobile CBD Store on Wheels.
Via
Benzinga
CBD Life Sciences, Inc. (CBDL) Executes Partnership with Arizona's Largest CBD Wholesaler
April 04, 2023
Via
ACCESSWIRE
CBD Life Sciences Launches CBD Home Delivery Service Across Phoenix-Scottsdale Metro Area
February 07, 2023
CBD Life Sciences (OTCPK:CBDL), through its wholly owned subsidiary, LBC Bioscience Inc., announced that the company is beginning to offer same day home delivery for all CBD products across the...
Via
Benzinga
CBD Life Sciences, Inc. (CBDL) Launches CBD Home Delivery Service Across Phoenix-Scottsdale Metro Area
February 07, 2023
Via
ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Launches Premium Terpene Infused Oil
January 11, 2023
Via
ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Reports: Marijuana-Cannabidiol (CBD) Bill Signals New Era in Federal Cannabis Policy
November 29, 2022
Via
ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Announces Mobile CBD Store on Wheels
October 20, 2022
Via
ACCESSWIRE
CBD Life Sciences Developing Bladder Control Supplement
September 21, 2022
LBC Bioscience Inc., a wholly owned subsidiary of CBD Life Sciences, (OTCPK:CBDL) is working towards launching a bladder control supplement.
Via
Benzinga
CBD Life Sciences, Inc. (CBDL) Announces Bladder Control Supplement
September 21, 2022
Via
ACCESSWIRE
CBD Life Sciences Debuts New Delta-9 Gummies With 400Mg of CBD
April 05, 2022
LBC Bioscience Inc., a wholly-owned subsidiary of CBD Life Sciences (OTCPK:CBDL) is introducing new powerful Delta-9 Gummies.
Via
Benzinga
CBD Life Sciences Launches Delta-9 + Delta-8 Infused Gummies
August 18, 2022
CBD Life Sciences (OTCPK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. is introducing a product that is infused with both Delta-8 & Delta-9.
Via
Benzinga
CBD Life Sciences, Inc. (CBDL) Distributes NEW Infused Gummies Nationwide
August 18, 2022
Via
ACCESSWIRE
CBD Life Sciences, Inc. (CBDL) Confirms the Launching of Delta-8 Infused Snacks
July 14, 2022
SCOTTSDALE, AZ / ACCESSWIRE / July 14, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is proud to launch its...
From
CBD Life Sciences Inc.
Via
AccessWire
CBD Life Sciences, Inc. (CBDL) Announces New Laboratory Operation Launched at CBD Vault
June 30, 2022
SCOTTSDALE, AZ / ACCESSWIRE / June 30, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has begun starting a New...
From
CBD Life Sciences Inc.
Via
AccessWire
CBD Life Sciences, Inc. (CBDL) Set to Attend White Label Expo in Las Vegas
May 19, 2022
SCOTTSDALE, AZ / ACCESSWIRE / May 19, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announced today that the company is set to attend the White...
From
CBD Life Sciences Inc.
Via
AccessWire
CBD Life Sciences, Inc. (CBDL) Debuts New Delta-9 Gummies
April 05, 2022
SCOTTSDALE, AZ / ACCESSWIRE / April 5, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is introducing new...
From
CBD Life Sciences Inc.
Via
AccessWire
CBD Life Sciences, Inc. (CBDL) Set to Present at ERRL Cup Cannabis Event
March 10, 2022
SCOTTSDALE, AZ / ACCESSWIRE / March 10, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is going to be all set...
From
CBD Life Sciences Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
CBD Vegan Gummies Reach Amazon, CBD Life Sciences Confirms
February 10, 2022
CBD Life Sciences (OTC: CBDL) via its wholly owned subsidiary, LBC Bioscience Inc. is launching its top selling 300MG strawberry lemonade vegan gummies on Amazon (NASDAQ: AMZN) by the end of this...
Via
Benzinga
CBD Life Sciences, Inc. (CBDL) Announces Launch of Vegan Gummies on Amazon Platform
February 10, 2022
SCOTTSDALE, AZ / ACCESSWIRE / February 10, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is going to be...
From
CBD Life Sciences Inc.
Via
AccessWire
CBD Life Sciences, Inc. (CBDL) Introduces Production of HHC Products
February 02, 2022
SCOTTSDALE, AZ / ACCESSWIRE / February 2, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is going to be...
From
CBD Life Sciences Inc.
Via
AccessWire
CBD Life Sciences, Inc. (CBDL) Releases Letter to Shareholders
January 26, 2022
SCOTTSDALE, AZ / ACCESSWIRE / January 26, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company will be releasing a...
From
CBD Life Sciences Inc.
Via
AccessWire
CBD Life Sciences, Inc. (CBDL) Looking to expand its Hemp Product Line in Europe
December 21, 2021
SCOTTSDALE, AZ / ACCESSWIRE / December 21, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces that the company is currently exploring and...
From
CBD Life Sciences Inc.
Via
AccessWire
CBD Life Sciences, Inc. (CBDL) Introduces First Bitcoin ATM Machine at Retail Location
December 14, 2021
SCOTTSDALE, AZ / ACCESSWIRE / December 14, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces that the company is going to be placing a...
From
CBD Life Sciences Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.